The risk of development and progression of diabetic retinopathy in a group of ethnically diverse pregnant women with diabetes attending three regional Diabetic Eye Screening Programs in the UK
The risk of development and progression of diabetic retinopathy in a group of ethnically diverse pregnant women with diabetes attending three regional Diabetic Eye Screening Programs in the UK
Background/Objectives: currently, all pregnant women with diabetes are asked to attend screening at least twice during pregnancy, even if no retinopathy is detected in early pregnancy. We hypothesise that for women with no diabetic retinopathy in early pregnancy, the frequency of retinal screening may be safely reduced.
Subjects/Methods: in this retrospective cohort study, data for 4718 pregnant women attending one of three UK Diabetic Eye Screening (DES) Programmes between July 2011 and October 2019 was extracted. The women’s UK DES grades at 13 weeks gestation (early pregnancy) and 28 weeks gestation (late pregnancy) were recorded. Descriptive statistics were used to report baseline data. Ordered logistic regression was used to control for covariates, such as age, ethnicity, diabetes duration, and diabetes type.
Results: of the women with grades recorded for both early and late pregnancy, a total of 3085 (65.39%) women had no retinopathy in early pregnancy, and 2306 (74.7%) of these women did not develop any retinopathy by 28 weeks. The number of women without retinopathy in early pregnancy who developed referable retinopathy was 14 (0.45%), none of whom required treatment. Diabetic Retinopathy in early pregnancy remained a significant predictor of DES grade in late pregnancy when covariates of Age, Ethnicity, and Diabetes Type were controlled for (P < 0.001).
Conclusions: in summary, this study has demonstrated that the burden of managing diabetes for pregnant mothers may be safely reduced by limiting the number of diabetic eye screening appointments in women who have no retinal changes in early pregnancy. Screening of women with retinopathy in early pregnancy should continue in line with current UK guidance.
179-184
Clarke, Kirsty
6cd80d76-589e-4bb1-9f5b-57a6309806b3
Webster, Laura
a48fab30-ef29-454e-a718-f4a4784104a4
Althauser, Susanne
cf505803-e321-42ee-bd75-7ddf411eb8f6
Anderson, John
434cecfa-571c-4d7b-ab6a-95966653c959
Stratton, Irene
772f25b9-23c0-4240-a3f6-1e76b03b172f
Brackenridge, Anna
5fb284ce-755d-4b3e-9c8b-17c76fe2406a
Mann, Samantha S.
aab1d99f-8e26-4f5b-9530-47b45aa0371b
1 January 2024
Clarke, Kirsty
6cd80d76-589e-4bb1-9f5b-57a6309806b3
Webster, Laura
a48fab30-ef29-454e-a718-f4a4784104a4
Althauser, Susanne
cf505803-e321-42ee-bd75-7ddf411eb8f6
Anderson, John
434cecfa-571c-4d7b-ab6a-95966653c959
Stratton, Irene
772f25b9-23c0-4240-a3f6-1e76b03b172f
Brackenridge, Anna
5fb284ce-755d-4b3e-9c8b-17c76fe2406a
Mann, Samantha S.
aab1d99f-8e26-4f5b-9530-47b45aa0371b
Clarke, Kirsty, Webster, Laura, Althauser, Susanne, Anderson, John, Stratton, Irene, Brackenridge, Anna and Mann, Samantha S.
(2024)
The risk of development and progression of diabetic retinopathy in a group of ethnically diverse pregnant women with diabetes attending three regional Diabetic Eye Screening Programs in the UK.
Eye (Basingstoke), 38 (1), .
(doi:10.1038/s41433-023-02655-0).
Abstract
Background/Objectives: currently, all pregnant women with diabetes are asked to attend screening at least twice during pregnancy, even if no retinopathy is detected in early pregnancy. We hypothesise that for women with no diabetic retinopathy in early pregnancy, the frequency of retinal screening may be safely reduced.
Subjects/Methods: in this retrospective cohort study, data for 4718 pregnant women attending one of three UK Diabetic Eye Screening (DES) Programmes between July 2011 and October 2019 was extracted. The women’s UK DES grades at 13 weeks gestation (early pregnancy) and 28 weeks gestation (late pregnancy) were recorded. Descriptive statistics were used to report baseline data. Ordered logistic regression was used to control for covariates, such as age, ethnicity, diabetes duration, and diabetes type.
Results: of the women with grades recorded for both early and late pregnancy, a total of 3085 (65.39%) women had no retinopathy in early pregnancy, and 2306 (74.7%) of these women did not develop any retinopathy by 28 weeks. The number of women without retinopathy in early pregnancy who developed referable retinopathy was 14 (0.45%), none of whom required treatment. Diabetic Retinopathy in early pregnancy remained a significant predictor of DES grade in late pregnancy when covariates of Age, Ethnicity, and Diabetes Type were controlled for (P < 0.001).
Conclusions: in summary, this study has demonstrated that the burden of managing diabetes for pregnant mothers may be safely reduced by limiting the number of diabetic eye screening appointments in women who have no retinal changes in early pregnancy. Screening of women with retinopathy in early pregnancy should continue in line with current UK guidance.
Text
s41433-023-02655-0
- Version of Record
More information
Accepted/In Press date: 21 June 2023
Published date: 1 January 2024
Additional Information:
© 2023. The Author(s).
Identifiers
Local EPrints ID: 487212
URI: http://eprints.soton.ac.uk/id/eprint/487212
ISSN: 0950-222X
PURE UUID: ce75f6b4-271c-4a22-b9cf-747bcfbaceb8
Catalogue record
Date deposited: 16 Feb 2024 10:31
Last modified: 16 Apr 2024 02:00
Export record
Altmetrics
Contributors
Author:
Kirsty Clarke
Author:
Laura Webster
Author:
Susanne Althauser
Author:
John Anderson
Author:
Irene Stratton
Author:
Anna Brackenridge
Author:
Samantha S. Mann
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics